BIAF Surges 13% in Pre-Market — But What's Fueling the Breakout?

Why is bioAffinity (BIAF) stock rising sharply in pre-market trading?

bioAffinity (Nasdaq: BIAF) stock is surging more than 13% in pre-market trading on March 20, 2026, after opening at $3.01 and reaching a high of $3.74. The move has put the micro-cap stock well above its 20-day high of $3.09, signaling a potential breakout. Despite broader market weakness—with the Nasdaq futures down 0.37% and S&P 500 futures declining 0.25—BIAF’s move is catching attention.

The rally comes amid growing interest in the company’s CyPath Lung diagnostic product line. Recent clinical case studies, particularly one involving a 71-year-old former smoker, highlighted the non-invasive lung cancer diagnostic tool’s ability to avoid unnecessary procedures. This, along with a 99% growth in CyPath Lung test volume in 2025 and 87% revenue growth, has fueled market optimism.

That said, the timing of the rally is somewhat unclear. While the clinical and revenue news is recent, it predates the current pre-market move. This suggests the catalyst may be more psychological than direct, with traders reacting to broader confidence in the product’s trajectory.

Still, volume is a key factor here. BIAF’s pre-market volume of 2.36 million shares is sharply above its 20-day average, indicating active participation. The stock’s relative volume is also strong at 11.7x, pointing to a surge in buying interest. However, the stock’s volatility remains high, with an average true range (ATR) of 0.37, so caution is warranted.

What key technical levels are in play for BIAF stock today?

From a technical standpoint, BIAF is breaking out of a 20-day range that extended from $0.90 to $3.09. The stock is currently trading at $3.36, which is in the upper end of the 60-day range and well above the 20-day moving average of $1.31 and 50-day moving average of $1.23. RSI stands at 74.06, indicating near-overbought conditions.

The nearest resistance level is at $4.00, and the nearest support is at $3.00. A close above $4.00 would confirm a breakout, while a drop below $3.00 could signal a pullback or even a failed move.

In practice, traders are watching for two key things: whether the price stays above $3.00 and whether volume continues to support the move. A failure to hold above $3.00 would raise concerns about the sustainability of the rally.

Crucially, the stock is still in the "pending" stage of the breakout. Until it confirms a sustained move above $3.09 or breaks below $3.00, the trade remains in flux.

What are the possible outcomes for bioAffinity (BIAF) stock in the coming days?

BIAF has four main scenarios in the next few trading days, though none are highly probable due to the low confidence level in the catalyst and the uncertainty of the setup.

The top scenario is a continuation of the bullish trend, with price targets at $3.66 (price + 0.8×ATR) and $3.92 (price + 1.5×ATR). This would require the stock to stay above $3.00 and for volume to continue showing strength. That said, a failure to maintain momentum could trigger a pullback.

By contrast, a failure scenario is also on the table. If the stock drops below $3.00 or re-enters the 20-day range, the bullish thesis weakens, and a reversal becomes more likely. In practice, the stock’s current ATR and RSI suggest that volatility remains a key risk.

At the end of the day, the stock is showing signs of a breakout, but the thin pre-market liquidity and lack of a clear catalyst mean that the move could be fragile. Retail and professional traders should watch closely for a confirmation or breakdown.

The bottom line is to monitor the $3.00 support level and $4.00 resistance level. If BIAF holds above $3.00, it could continue the trend; if it fails, the stock may re-enter a trading range or even reverse direction. Volume and price action over the next couple of sessions will be key.

BIAF support and resistance levels to watch in the coming sessions

• Key Support: $3.00 — A breakdown below this level would indicate a failed breakout or a significant pullback.
• Key Resistance: $4.00 — A close above this level would confirm the breakout and open the door for further gains.
• Intermediate Support/Resistance: $3.09 (20-day high) — A retest of this level could offer another chance for a breakout confirmation.
• Longer-Term Moving Averages: MA20 at $1.31, MA50 at $1.23 — These could act as dynamic support levels if the stock retraces.

Traders should also keep an eye on volume over the next 1–2 sessions. A relative volume below 1.5× the 20-day average could signal a slowdown, while a continued surge in volume may point to a stronger continuation of the move.

In fairness, the lack of a strong catalyst and the pending nature of the breakout mean that volatility could remain high. A sudden news update or earnings release could quickly shift sentiment, so investors should remain flexible and watch for any developments from the company.